CTMX
CytomX Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.68
-0.19 ▼ -3.90%
🌙 3월 13일 7:58 PM ET (한국 3/14 08:58)
$4.89
+0.21 ▲ +4.49%
| Index | - | P/E | 11.19 | EPS (ttm) | 0.42 | Insider Own | 21.82% | Shs Outstand | 0.17B | Perf Week | - |
| Market Cap | 0.79B | Forward P/E | - | EPS next Y | -1269% | Insider Trans | -0.27% | Shs Float | 0.13B | Perf Month | -15.83% |
| Enterprise Value | 0.65B | PEG | - | EPS next Q | -0.09 | Inst Own | 72.14% | Short Float | 14.24% | Perf Quarter | 20% |
| Income | 0.03B | P/S | 6.98 | EPS this Y | -107.36% | Inst Trans | 0.95% | Short Ratio | 5.78 | Perf Half Y | 123.92% |
| Sales | 0.11B | P/B | 7.19 | EPS next 5Y | - | ROA | 18.85% | Short Interest | 18.86M | Perf YTD | 9.86% |
| Book/sh | 0.65 | P/C | 5.52 | EPS past 3/5Y | - | ROE | 66.76% | 52W High | -26.3% ($6.35) | Perf Year | 692.15% |
| Cash/sh | 0.85 | P/FCF | - | Sales past 3/5Y | 54.69% 19.16% | ROIC | 26.09% | 52W Low | 1070% ($0.40) | Perf 3Y | 140% |
| Dividend Est. | - | EV/EBITDA | 26.81 | EPS Y/Y TTM | 144.62% | Gross Margin | 98.87% | Volatility(W/M) | 7.09% 6.42% | Perf 5Y | -44.94% |
| Dividend TTM | - | EV/Sales | 5.76 | Sales Y/Y TTM | -10.26% | Oper. Margin | 20.37% | ATR (14) | 0.36 | Perf 10Y | -64.46% |
| Dividend Ex-Date | - | Quick Ratio | 3.64 | EPS Q/Q | -228.08% | Profit Margin | 24.66% | RSI (14) | 40.52 | Recom | 1.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.64 | Sales Q/Q | -82.16% | SMA20 | -9.62% ($5.18) | Beta | 2.49 | Target Price | $9 |
| Payout | - | Debt/Eq | 0.05 | Earnings | 3000000 | SMA50 | -8.98% ($5.14) | Rel Volume | 0.88 | Prev Close | $4.87 |
| Employees | 121 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -82.56% -47.84% | SMA200 | 34.32% ($3.48) | Avg Volume(3M) | 3.26M | Price | $4.68 |
| IPO | 2015/10/8 | Option/Short | Yes/Yes | Trades | 12195 | Volume | 2,864,938 | Change | -3.9% |
뉴스 로딩 중...